Implementing High-Sensitivity Cardiac Troponin Testing Pathways
-
By
-
James S. Ford
-
William B. Stubblefield
-
Jesse O. Wrenn
-
November 10, 2026
Clinical Scorecard: Implementing High-Sensitivity Cardiac Troponin Testing Pathways
At a Glance
Category | Detail |
|---|---|
Condition | Suspected acute myocardial infarction (AMI) in patients presenting to the emergency department (ED) with chest pain or other anginal equivalents. |
Key Mechanisms | High-sensitivity cardiac troponin (hs-cTn) assays detect low-level myocardial injury. Increased serial testing may reflect both assay sensitivity and pathway-driven repeat sampling. The reported EHR-integrated pathway used conditional serial orders, shared pathway status and timing, and a final evaluation interpretation. |
Target Population | Patients with chest pain who underwent cardiac troponin testing in the ED; the article also discusses patients with other anginal equivalents. |
Care Setting | Four urban emergency departments using an EHR-integrated hs-cTn testing pathway. |
Key Highlights
The Fifth Universal Definition of Myocardial Infarction recommends adding hs-cTn to accelerated diagnostic pathways.
An EHR-integrated hs-cTn pathway across four urban EDs was associated with an approximately 30-minute decrease in ED length of stay among patients with chest pain who underwent troponin testing.
The greatest reductions in time occurred among patients requiring serial troponin assays; the intervention included conditional serial orders, shared pathway status and timing, and a final evaluation interpretation.
The hs-cTn period had more serial troponin measurements and more 30-day AMI diagnoses, without a corresponding rise in 30-day PCI or ED cardiology consultation.
The study did not assess patient-centered outcomes such as missed AMI, readmissions, or mortality, and its pre-post design cannot isolate the effects of the assay from the pathway and workflow changes.
Guideline-Based Recommendations
Diagnosis
The Fifth Universal Definition of Myocardial Infarction recommends adding hs-cTn to accelerated diagnostic pathways.
The article discusses interpreting increased serial testing and additional myocardial injury diagnoses in light of assay sensitivity and pathway-driven repeat sampling.
Management
The reported intervention integrated conditional serial orders, shared pathway status and timing, and a final evaluation interpretation into the EHR workflow.
The article states that the clinical value of additional diagnoses depends in part on whether they appropriately alter management and improve patient-centered outcomes.
Monitoring & Follow-up
The article calls for future research on broader ED crowding measures, including leaving without being seen and time to initial clinician evaluation.
The article identifies missed AMI and patient outcomes as important considerations when evaluating hs-cTn pathways.
Risks
Greater sensitivity and protocolized serial measurement may increase repeat testing and recognition of myocardial injury.
The clinical value of additional diagnoses and the consequences of unnecessary testing remain incompletely characterized.
The pre-post design is vulnerable to unmeasured influences and secular trends; the source excerpt is truncated before its full discussion of generalizability.
Patient & Prescribing Data
Patients with chest pain who underwent cardiac troponin testing in the emergency department; the article also discusses other anginal equivalents.
The article concerns diagnostic testing pathways rather than a medication treatment. In the reported study, the hs-cTn pathway was associated with shorter ED length of stay and more 30-day AMI diagnoses; missed AMI, readmissions, and mortality were not assessed.
Clinical Best Practices
The reported intervention integrated the hs-cTn pathway into the EHR and clinical workflow.
The intervention displayed pathway status and timing, conditionally released serial orders, and incorporated a final evaluation interpretation.
The article argues that operational efficiency should be evaluated alongside downstream testing, diagnoses, interventions, and patient outcomes.
Interpret the reported findings in light of the pre-post design and the multifaceted intervention.
Related Resources & Content
2025 ACC/AHA/ACEP/NAEMSP/SCAI, American Heart Association, 2025 — Guideline for the Management of Patients With Acute Coronary Syndromes
MDSpire News, n.d. — Putting a POC Troponin to the Test
MDSpire News, n.d. — Troponin Testing and Early MI Discharge
JAMA Cardiology, n.d. — Early Rule Out of Myocardial Infarction With a Novel High-Sensitivity Cardiac Troponin T Assay
The Lancet, 2026 — Safety and efficacy of the 0/1 h pathway for myocardial infarction in the emergency department: an international, pragmatic, stepped-wedge, cluster-randomised, controlled trial
Authors not specified in supplied material, n.d. — Performance of 0/1 h versus 0/3 h pathways in patients with suspected myocardial infarction: a systematic review and individual participant data meta-analysis of randomised controlled trials
the pathologist — Troponin at the Heart of it
2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes
Safety and efficacy of the 0/1 h pathway for myocardial infarction in the emergency department: an international, pragmatic, stepped-wedge, cluster-randomised, controlled trial
Performance of 0/1 h versus 0/3 h pathways in patients with suspected myocardial infarction: a systematic review and individual participant data meta-analysis of randomised controlled trials
Putting a POC Troponin to the Test
Troponin Testing and Early MI Discharge
Based on findings from:
Operationalizing High-Sensitivity Cardiac Troponin Pathways
James S. Ford, William B. Stubblefield, Jesse O. Wrenn. Jama Network Open, 2026.
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2856374
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.